Reducing Chronic Obstructive Pulmonary Disease Hospital Readmissions. An Official American Thoracic Society Workshop Report

Valerie G Press, David H Au, Jean Bourbeau, Mark T Dransfield, Andrea S Gershon, Jerry A Krishnan, Richard A Mularski, Frank C Sciurba, Jamie Sullivan, Laura C Feemster, Valerie G Press, David H Au, Jean Bourbeau, Mark T Dransfield, Andrea S Gershon, Jerry A Krishnan, Richard A Mularski, Frank C Sciurba, Jamie Sullivan, Laura C Feemster

Abstract

Chronic obstructive pulmonary disease (COPD) is the third leading cause of hospital readmissions in the United States. The quality of care delivered to patients with COPD is known to be lacking across the care continuum, and may contribute to high rates of readmission. As part of the response to these issues, the Centers for Medicare and Medicaid instituted a penalty for 30-day readmissions as part of their Hospital Readmission Reduction Program in October 2014. At the time the penalty was instated, there was little published evidence on effective hospital-based programs to reduce readmissions after acute exacerbations of COPD. Even now, several years later, few published programs exist, and we continue to lack consistent approaches that lead to improved readmission rates. In addition, there was concern that the penalty would widen health disparities. Despite the dearth of published evidence to reduce readmissions beyond available COPD guidelines, many hospitals across the United States began to develop and implement programs, based on little evidence, due to the financial penalty. We, therefore, assembled a diverse group of clinicians, researchers, payers, and program leaders from across the country to present and discuss approaches that had the greatest potential for success. We drew on expertise from ongoing readmission reduction programs, implementation methodologies, and stakeholder perspectives to develop this Workshop Report on current best practices and models for addressing COPD hospital readmissions.

Keywords: COPD; evidence-based care; quality of care; readmissions; value-based care.

Figures

Figure 1.
Figure 1.
Chronic obstructive pulmonary disease (COPD) Foundation Second COPD Readmission Summit: “A few ‘best practices’.” f/u = follow-up; PR = pulmonary rehabilitation.

References

    1. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360:1418–1428.
    1. Lindenauer PK, Pekow P, Gao S, Crawford AS, Gutierrez B, Benjamin EM. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2006;144:894–903.
    1. Han MK, Martinez CH, Au DH, Bourbeau J, Boyd CM, Branson R, et al. Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective. Lancet Respir Med. 2016;4:473–526.
    1. Centers for Medicare & Medicaid ServicesMedicare C for Baltimore. MS 7500 SB, USA. Readmissions-Reduction-Program. 2016. Apr 18 [accessed 2017 Mar 12]. Available from:
    1. Shah T, Press VG, Huisingh-Scheetz M, White SR. COPD readmissions: addressing COPD in the era of value-based health care. Chest. 2016;150:916–926.
    1. Joynt KE, Jha AK. Characteristics of hospitals receiving penalties under the Hospital Readmissions Reduction Program. JAMA. 2013;309:342–343.
    1. Joynt KE, Jha AK. A path forward on Medicare readmissions. N Engl J Med. 2013;368:1175–1177.
    1. Joynt KE, Figueroa JE, Oray J, Jha AK. Opinions on the Hospital Readmission Reduction Program: results of a national survey of hospital leaders. Am J Manag Care. 2016;22:e287–e294.
    1. Carey K, Lin M-Y. Hospital Readmissions Reduction Program: safety-net hospitals show improvement, modifications to penalty formula still needed. Health Aff (Millwood) 2016;35:1918–1923.
    1. Stern JM, Simes RJ. Publication bias: evidence of delayed publication in a cohort study of clinical research projects. BMJ. 1997;315:640–645.
    1. ODPHP. Healthy People 2020. Social determinants of health. Washington, DC: Office of Disease Prevention and Health Promotion; 2014 [accessed 2018 Sep 19]. Available from:
    1. Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2018 Report). Global Initiative for Chronic Obstructive Lung Disease. Final revised 2017 Nov 20 [accessed 2018 Jun 3]. Available from:
    1. Bhatt SP, Wells JM, Iyer AS, Kirkpatrick DP, Parekh TM, Leach LT, et al. Results of a Medicare bundled payments for care improvement initiative for chronic obstructive pulmonary disease readmissions. Ann Am Thorac Soc. 2017;14:643–648.
    1. Press VG, Konetzka RT, White SR. Insights about the economic impact of chronic obstructive pulmonary disease readmissions post implementation of the Hospital Readmission Reduction Program. Curr Opin Pulm Med. 2018;24:138–146.
    1. Gupta A, Allen LA, Bhatt DL, Cox M, DeVore AD, Heidenreich PA, et al. Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure. JAMA Cardiol. 2018;3:44–53.
    1. Press VG. Is it time to move on from identifying risk factors for 30-day chronic obstructive pulmonary disease readmission? A call for risk prediction tools. Ann Am Thorac Soc. 2018;15:801–803.
    1. Echevarria C, Steer J, Heslop-Marshall K, Stenton SC, Hickey PM, Hughes R, et al. The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD. Thorax. 2017;72:686–693.
    1. Garcia-Aymerich J, Farrero E, Félez MA, Izquierdo J, Marrades RM, Antó JM Estudi del Factors de Risc d’Agudització de la MPOC investigators. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax. 2003;58:100–105.
    1. Amalakuhan B, Kiljanek L, Parvathaneni A, Hester M, Cheriyath P, Fischman D.A prediction model for COPD readmissions: catching up, catching our breath, and improving a national problem J Community Hosp Intern Med Perspect 20122DOI: 10.3402/jchimp.v2i1.9915.
    1. Baker CL, Zou KH, Su J. Risk assessment of readmissions following an initial COPD-related hospitalization. Int J Chron Obstruct Pulmon Dis. 2013;8:551–559.
    1. Chenna PR, Mannino DM. Outcomes of severe COPD exacerbations requiring hospitalization. Semin Respir Crit Care Med. 2010;31:286–294.
    1. Halpin DMG, Miravitlles M. Chronic obstructive pulmonary disease: the disease and its burden to society. Proc Am Thorac Soc. 2006;3:619–623.
    1. Kanervisto M, Paavilainen E, Heikkilä J. Family dynamics in families of severe COPD patients. J Clin Nurs. 2007;16:1498–1505.
    1. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:1418–1422.
    1. Esteban C, Quintana JM, Moraza J, Aburto M, Egurrola M, España PP, et al. Impact of hospitalisations for exacerbations of COPD on health-related quality of life. Respir Med. 2009;103:1201–1208.
    1. Aimonino N, Tibaldi V, Barale S, Bardelli B, Pilon S, Marchetto C, et al. Depressive symptoms and quality of life in elderly patients with exacerbation of chronic obstructive pulmonary disease or cardiac heart failure: preliminary data of a randomized controlled trial. Arch Gerontol Geriatr. 2007;44:7–12.
    1. Chow L, Parulekar AD, Hanania NA. Hospital management of acute exacerbations of chronic obstructive pulmonary disease. J Hosp Med. 2015;10:328–339.
    1. Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60:925–931.
    1. Fruchter O, Yigla M. Predictors of long-term survival in elderly patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Respirology. 2008;13:851–855.
    1. Lindenauer PK, Dharmarajan K, Qin L, Lin Z, Gershon AS, Krumholz HM. Risk trajectories of readmission and death in the first year after hospitalization for chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;197:1009–1017.
    1. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest. 2000;117(2 s) uppl:5S–9S.
    1. Prieto Centurion V, Huang F, Naureckas ET, Camargo CA, Jr, Charbeneau J, Joo MJ, et al. Confirmatory spirometry for adults hospitalized with a diagnosis of asthma or chronic obstructive pulmonary disease exacerbation. BMC Pulm Med. 2012;12:73.
    1. Gershon AS, Hwee J, Croxford R, Aaron SD, To T. Patient and physician factors associated with pulmonary function testing for COPD: a population study. Chest. 2014;145:272–281.
    1. Gershon A, Mecredy G, Croxford R, To T, Stanbrook MB, Aaron SD Canadian Respiratory Research Network. Outcomes of patients with chronic obstructive pulmonary disease diagnosed with or without pulmonary function testing. CMAJ. 2017;189:E530–E538.
    1. Gershon AS, Thiruchelvam D, Chapman KR, Aaron SD, Stanbrook MB, Bourbeau J, et al. Canadian Respiratory Research Network. Health services burden of undiagnosed and overdiagnosed COPD. Chest. 2018;153:1336–1346.
    1. Wu H, Wise RA, Medinger AE. Do patients hospitalized with COPD have airflow obstruction? Chest. 2017;151:1263–1271.
    1. Press VG, Arora VM, Shah LM, Lewis SL, Ivy K, Charbeneau J, et al. Misuse of respiratory inhalers in hospitalized patients with asthma or COPD J Gen Intern Med 201126635–642.[Published erratum appears in J Gen Intern Med 26:458.].
    1. Press VG, Arora VM, Shah LM, Lewis SL, Charbeneau J, Naureckas ET, et al. Teaching the use of respiratory inhalers to hospitalized patients with asthma or COPD: a randomized trial. J Gen Intern Med. 2012;27:1317–1325.
    1. Press VG, Arora VM, Trela KC, Adhikari R, Zadravecz FJ, Liao C, et al. Effectiveness of interventions to teach metered-dose and diskus inhaler techniques: a randomized trial. Ann Am Thorac Soc. 2016;13:816–824.
    1. Patel MR, Press VG, Gerald LB, Barnes T, Blake K, Brown LK, et al. Assembly on Behavioral Sciences and Health Services Research. Improving the affordability of prescription medications for people with chronic respiratory disease: an official American Thoracic Society policy statement. Am J Respir Crit Care Med. 2018;198:1367–1374.
    1. Goldfield NI, McCullough EC, Hughes JS, Tang AM, Eastman B, Rawlins LK, et al. Identifying potentially preventable readmissions. Health Care Financ Rev. 2008;30:75–91.
    1. Prieto-Centurion V, Markos MA, Ramey NI, Gussin HA, Nyenhuis SM, Joo MJ, et al. Interventions to reduce rehospitalizations after chronic obstructive pulmonary disease exacerbations: a systematic review. Ann Am Thorac Soc. 2014;11:417–424.
    1. Krishnan JA, Gussin HA, Prieto-Centurion V, Sullivan JL, Zaidi F, Thomashow BM. Integrating COPD into patient-centered hospital readmissions reduction programs. Chronic Obstr Pulm Dis (Miami) 2015;2:70–80.
    1. Celli BR, MacNee W ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932–946.
    1. Global Initiative for Chronic Obstructive Lung Disease. GOLD 2017: Global Strategy for the Diagnosis, Management and Prevention of COPD. Final revised 2017 Nov 20 [accessed 2017 Mar 12]. Available from:
    1. Feemster LC, Au DH. Penalizing hospitals for chronic obstructive pulmonary disease readmissions. Am J Respir Crit Care Med. 2014;189:634–639.
    1. Sjoding MW, Cooke CR. Readmission penalties for chronic obstructive pulmonary disease will further stress hospitals caring for vulnerable patient populations. Am J Respir Crit Care Med. 2014;190:1072–1074.
    1. Prescott E, Vestbo J. Socioeconomic status and chronic obstructive pulmonary disease. Thorax. 1999;54:737–741.
    1. Gershon AS, Dolmage TE, Stephenson A, Jackson B. Chronic obstructive pulmonary disease and socioeconomic status: a systematic review. COPD. 2012;9:216–226.
    1. COPD Foundation releases groundbreaking COPE survey results: low patient awareness about COPD exacerbations poses barrier to effective management [new release]. Washington, DC: COPD Foundation. 2014 Jun 17 [accessed 2018 Jul 3]. Available from:
    1. Willard KS, Sullivan JB, Thomashow BM, Jones CS, Fromer L, Yawn BP, et al. The 2nd National COPD Readmissions Summit and beyond: from theory to implementation. Chronic Obstr Pulm Dis. 2016;3:778–790.
    1. Washington State Health Care Authority. Data and reports. 2018 [accessed 2018 Jul 17]. Available from:
    1. . Text of H.R. 3590 (111th): Patient Protection and Affordable Care Act (Passed Congress version). . 2010 Mar 23 [accessed 2018 Apr 7]. Available from:
    1. Government of Ontario M of H and L-TC. Excellent Care for all—health care professionals—MOHLTC. 2013 Dec 30 [accessed 2018 Jul 3]. Available from:
    1. Lung Foundation Australia. COPD Guidelines: The COPD-X Plan. 2018 Aug [accessed 2018 Jul 3]. Available from:
    1. Lung Foundation Australia. C.O.P.E—COPD Online Patient Education Program. Lung Foundation Australia. 2019 [accessed 2018 Jul 3]. Available from:
    1. Lindenauer P, Au D, Chang W, LaBrin J, Mularski R, Press V.COPD Implementation Toolkit. 2019 [accessed 2019 Jan 7]. Available from:
    1. Donzé JD, Williams MV, Robinson EJ, Zimlichman E, Aujesky D, Vasilevskis EE, et al. International Validity of the HOSPITAL Score to Predict 30-Day Potentially Avoidable Hospital Readmissions. JAMA Intern Med. 2016;176:496–502.
    1. Centers for Medicare & Medicaid Services. Bundled Payments for Care Improvement (BPCI) Initiative: general information. Center for Medicare & Medicaid Innovation. 2018 Dec 11 [accessed 2017 Mar 12]. Available from:
    1. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. ATS/ERS Task Force on Pulmonary Rehabilitation. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188:e13–e64.
    1. Ursan ID, Krishnan JA, Pickard AS, Calhoun E, DiDomenico R, Prieto-Centurion V, et al. Engaging patients and caregivers to design transitional care management services at a minority serving institution. J Health Care Poor Underserved. 2016;27:352–365.
    1. Gershon AS, Macdonald EM, Luo J, Austin PC, Gupta S, Sivjee K, et al. Concomitant pulmonologist and primary care for chronic obstructive pulmonary disease: a population study. Fam Pract. 2017;34:708–716.
    1. Berkowitz RE, Fang Z, Helfand BKI, Jones RN, Schreiber R, Paasche-Orlow MK. Project ReEngineered Discharge (RED) lowers hospital readmissions of patients discharged from a skilled nursing facility. J Am Med Dir Assoc. 2013;14:736–740.
    1. Maynard GA, Budnitz TL, Nickel WK, Greenwald JL, Kerr KM, Miller JA, et al. 2011 John M. Eisenberg Patient Safety and Quality Awards. Mentored implementation: building leaders and achieving results through a collaborative improvement model: innovation in patient safety and quality at the national level. Jt Comm J Qual Patient Saf. 2012;38:301–310.
    1. Agency for Healthcare Research and Quality. Guide to Patient and Family Engagement in Hospital Quality and Safety: Strategy 4: care transitions from hospital to home: IDEAL discharge planning. 2017 Dec [accessed 2018 Mar 12]. Available from:

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere